GLUCAGON ANALOGUES
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; pol |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TOLBORG, JAKOB LIND RIBER, DITTE HAMPRECHT, DIETER WOLFGANG |
description | The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3057983TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3057983TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3057983TT33</originalsourceid><addsrcrecordid>eNrjZBBy9wl1dnT391Nw9HP08XcPdQ3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT7GBqbmlhbGISHGxsSoAQBJEx6Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLUCAGON ANALOGUES</title><source>esp@cenet</source><creator>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</creator><creatorcontrib>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</creatorcontrib><description>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</description><language>eng ; pol</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200518&DB=EPODOC&CC=PL&NR=3057983T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200518&DB=EPODOC&CC=PL&NR=3057983T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOLBORG, JAKOB LIND</creatorcontrib><creatorcontrib>RIBER, DITTE</creatorcontrib><creatorcontrib>HAMPRECHT, DIETER WOLFGANG</creatorcontrib><title>GLUCAGON ANALOGUES</title><description>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBy9wl1dnT391Nw9HP08XcPdQ3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT7GBqbmlhbGISHGxsSoAQBJEx6Y</recordid><startdate>20200518</startdate><enddate>20200518</enddate><creator>TOLBORG, JAKOB LIND</creator><creator>RIBER, DITTE</creator><creator>HAMPRECHT, DIETER WOLFGANG</creator><scope>EVB</scope></search><sort><creationdate>20200518</creationdate><title>GLUCAGON ANALOGUES</title><author>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3057983TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>TOLBORG, JAKOB LIND</creatorcontrib><creatorcontrib>RIBER, DITTE</creatorcontrib><creatorcontrib>HAMPRECHT, DIETER WOLFGANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOLBORG, JAKOB LIND</au><au>RIBER, DITTE</au><au>HAMPRECHT, DIETER WOLFGANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLUCAGON ANALOGUES</title><date>2020-05-18</date><risdate>2020</risdate><abstract>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; pol |
recordid | cdi_epo_espacenet_PL3057983TT3 |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
title | GLUCAGON ANALOGUES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOLBORG,%20JAKOB%20LIND&rft.date=2020-05-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3057983TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |